Published online 18 September 2000. doi:10.1083/jcb.150.6.1467
© The Rockefeller University Press,
0021-9525/2000//1467 $5.00
The Journal of Cell Biology, Volume 150, Number 6,
, 2000 1467-1478
A Novel Function for the Tumor Suppressor p16INK4a
: Induction of Anoikis via Upregulation of the
5β1 Fibronectin Receptor
Thomas Platha,
Katharina Detjena,
Martina Welzela,
Zofia von Marschalla,
Derek Murphya,
Michael Schirnerb,
Bertram Wiedenmanna, and
Stefan Rosewicza
a Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité, Campus Virchow-Klinikum
b Schering Experimentelle Onkologie, 13353 Berlin, Germany
Medizinische Klinik mit Schwerpunkt Hepatologie und Gastroenterologie, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany.49-30-450-5394049-30-450-53733
The tumor suppressor gene p16INK4a inhibits the kinase activity of the cyclin-dependent kinase 4–6/cyclin D complexes and subsequent phosphorylation of critical substrates necessary for transit through the G1 phase of the cell cycle. Recent studies suggested that control of the G1/S boundary might not be the sole biological function of p16INK4a. We hypothesized that p16INK4a might influence hitherto unknown critical features of a malignant epithelial phenotype, such as anchorage dependence. Here we provide evidence that stable transfection of p16INK4a restitutes apoptosis induction upon loss of anchorage (anoikis) in a variety of human cancer cells. Anoikis in p16INK4a-transfected cells was evidenced by DNA fragmentation and poly(ADP-ribose) polymerase cleavage upon cultivation on polyhydroxyethylmethacrylate-coated dishes and was associated with suppression of anchorage-independent growth as well as complete loss of tumorigenicity. p16INK4a-mediated anoikis was due to selective transcriptional upregulation of the
5 integrin chain of the
5β1 fibronectin receptor as detected by FACS® analysis, immunoprecipitation, Northern blotting, and nuclear run-on assays. Addition of soluble fibronectin and inhibitory
5 antibodies to nonadherent cells completely abolished p16INK4a-mediated anoikis, whereas laminin was ineffective. Furthermore, antisense-induced downregulation of the
5 integrin chain in p16INK4a-transfected cells restored resistance to anoikis. These data suggest a novel functional interference between a cell cycle–regulating tumor suppressor gene and membrane-bound integrins, thus regulating a hallmark feature of an epithelial transformed phenotype: susceptibility to anoikis.
Key Words: tumor suppressor p16INK4a anoikis fibronectin integrin tumorigenicity
© 2000 The Rockefeller University Press
Abbreviations used in this paper: Cdk, cyclin-dependent kinase; GAPDH, glyceraldehyde 3-phospate dehydrogenase; MDCK, Madin-Darby canine kidney; PARP, poly(ADP-ribose) polymerase; polyHEMA, polyhydroxyethylmethacrylate; Rb, retinoblastoma protein; TUNEL, terminal deoxynucleotidyl transferase–mediated dUTP biotin nick end labeling.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
Related Article
-
J. Cell Biol. 2000 150: 0-2.
[Full Text]
[PDF]
This article has been cited by other articles:
-
Wu, Y., Zuo, J., Ji, G., Saiyin, H., Liu, X., Yin, F., Cao, N., Wen, Y., Li, J. J., Yu, L.
(2009). Proapoptotic Function of Integrin {beta}3 in Human Hepatocellular Carcinoma Cells. Clin. Cancer Res.
15: 60-69
[Abstract]
[Full Text]
-
Rohwer, N., Welzel, M., Daskalow, K., Pfander, D., Wiedenmann, B., Detjen, K., Cramer, T.
(2008). Hypoxia-Inducible Factor 1{alpha} Mediates Anoikis Resistance via Suppression of {alpha}5 Integrin. Cancer Res.
68: 10113-10120
[Abstract]
[Full Text]
-
Marongiu, F., Doratiotto, S., Montisci, S., Pani, P., Laconi, E.
(2008). Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin?. Am. J. Pathol.
172: 857-864
[Abstract]
[Full Text]
-
Rao, J. S., Bhoopathi, P., Chetty, C., Gujrati, M., Lakka, S. S.
(2007). MMP-9 Short Interfering RNA Induced Senescence Resulting in Inhibition of Medulloblastoma Growth via p16INK4a and Mitogen-Activated Protein Kinase Pathway. Cancer Res.
67: 4956-4964
[Abstract]
[Full Text]
-
Fischer, C., Sanchez-Ruderisch, H., Welzel, M., Wiedenmann, B., Sakai, T., Andre, S., Gabius, H.-J., Khachigian, L., Detjen, K. M., Rosewicz, S.
(2005). Galectin-1 Interacts with the {alpha}5{beta}1 Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27. J. Biol. Chem.
280: 37266-37277
[Abstract]
[Full Text]
-
Chapman, E. J., Harnden, P., Chambers, P., Johnston, C., Knowles, M. A.
(2005). Comprehensive Analysis of CDKN2A Status in Microdissected Urothelial Cell Carcinoma Reveals Potential Haploinsufficiency, a High Frequency of Homozygous Co-deletion and Associations with Clinical Phenotype. Clin. Cancer Res.
11: 5740-5747
[Abstract]
[Full Text]
-
Hauff, P., Seemann, S., Reszka, R., Schultze-Mosgau, M., Reinhardt, M., Buzasi, T., Plath, T., Rosewicz, S., Schirner, M.
(2005). Evaluation of Gas-filled Microparticles and Sonoporation as Gene Delivery System: Feasibility Study in Rodent Tumor Models. Radiology
236: 572-578
[Abstract]
[Full Text]
-
Lee, I., Skinner, M. A., Guo, H.-b., Sujan, A., Pierce, M.
(2004). Expression of the Vacuolar H+-ATPase 16-kDa Subunit Results in the Triton X-100-insoluble Aggregation of {beta}1 Integrin and Reduction of Its Cell Surface Expression. J. Biol. Chem.
279: 53007-53014
[Abstract]
[Full Text]
-
Aguirre, A. J., Bardeesy, N., Sinha, M., Lopez, L., Tuveson, D. A., Horner, J., Redston, M. S., DePinho, R. A.
(2003). Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev.
17: 3112-3126
[Abstract]
[Full Text]
-
Lee, A. W. C., Li, J.-H., Shi, W., Li, A., Ng, E., Liu, T.-J., Klamut, H. J., Liu, F.-F.
(2003). p16 Gene therapy: A potentially efficacious modality for nasopharyngeal carcinoma. Molecular Cancer Therapeutics
2: 961-969
[Abstract]
[Full Text]
-
Martin, J. A., Forest, E., Block, J. A., Klingelhutz, A. J., Whited, B., Gitelis, S., Wilkey, A., Buckwalter, J. A.
(2002). Malignant Transformation in Human Chondrosarcoma Cells Supported by Telomerase Activation and Tumor Suppressor Inactivation. Cell Growth Differ.
13: 397-407
[Abstract]
[Full Text]
-
Hosotani, R., Miyamoto, Y., Fujimoto, K., Doi, R., Otaka, A., Fujii, N., Imamura, M.
(2002). Trojan p16 Peptide Suppresses Pancreatic Cancer Growth and Prolongs Survival in Mice. Clin. Cancer Res.
8: 1271-1276
[Abstract]
[Full Text]
-
Schwartz, M. A., Assoian, R. K.
(2002). Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci.
114: 2553-2560
[Abstract]
[Full Text]
-
Stupack, D. G., Puente, X. S., Boutsaboualoy, S., Storgard, C. M., Cheresh, D. A.
(2001). Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. JCB
155: 459-470
[Abstract]
[Full Text]
-
Lubomierski, N., Kersting, M., Bert, T., Muench, K., Wulbrand, U., Schuermann, M., Bartsch, D., Simon, B.
(2001). Tumor Suppressor Genes in the 9p21 Gene Cluster Are Selective Targets of Inactivation in Neuroendocrine Gastroenteropancreatic Tumors. Cancer Res.
61: 5905-5910
[Abstract]
[Full Text]